Loading
Avita Medical Inc. Stock: price and insider trades · Australia
1 insider bought shares over the last 90 days, the latest filed 05 Oct 2026.
Avita Medical Inc.: what insiders have been doing
Headquartered in Perth, Australia, Avita Medical Inc. is a listed company and traces its origins to 1993. Filings by its managers are published through ASX. The last twelve months, up to 18 October 2026, brought 3 filings signed by 1 insider.
Only purchases show up on the open market, 3 purchases in all, filed by 1 insider. The totals do not cover 3 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 1 senior executive.
The last insider purchase was made public on 5 October 2026, 12 days ago.
Compared with its exchange (2,222 companies, median 3 filings), a count of 3 filings is typical. Since 2026, the database holds 3 purchases and no sales by insiders of the company.
These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
3 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleUnknown3 buys
Since the insiders bought
- Unknown+258.3%Entry A$1.08 · Close 16 Oct 2026 A$3.87
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fundamental score
Ranked 18,491 of 24,148 companies
33.3
score / 100
Value20
Quality47
FCF yld-5.5%
Earn yld-8.1%
EV/EBITDA·
ROE·
Gross mgn82%
Net mgn-68%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
A$3.87
Analyst consensus
4 analysts2.33/5
A$2.20Target A$3.28(-15%)A$3.72
Income statement
RevenueA$71.6M
Gross profitA$58.8M82% margin
EBITDA-A$41.2M-58% margin
Net income-A$48.6M-57.0% margin
Valuation
PER (forward)-12.1x
Beta1.99
Balance sheet & cash
Market capA$598.4M
Total debtA$46M
Free Cash Flow-A$32.9M
Profitability & ownership
ROA-41.6%
% insiders0.2%
% institutions0.0%
Last declaration on 5 October 2026
About Avita Medical Inc.
Avita Medical Inc. is a company focused on developing tissue regeneration technologies. It is listed on the Australian Securities Exchange (ASX).
